Related by context. All words. (Click for frequent words.) 84 FDA Clears 82 Meets Primary Endpoint 82 Improves Survival 82 Announces FDA Clearance 81 Submits NDA 81 Initiate Clinical Trial 81 Expanded Indication 81 Receives Orphan Drug Designation 81 NDA Submission 81 FDA Okays 81 Gets FDA Clearance 81 IND Application 81 FDA Clearance 81 Demonstrates Significant 80 Generic Version 80 Completes Patient Enrollment 80 Generic Versions 80 Files IND 80 Drug Fails 80 Adjuvant Treatment 80 Receives Approvable Letter 80 Demonstrates Positive 80 Prolongs Survival 80 Improves Outcomes 80 Migraine Drug 80 Receives FDA Clearance 80 Drug Candidate 80 Patient Enrollment 79 Lupus Drug 79 Phase 2b Clinical Trial 79 Blood Pressure Drug 79 Initiates Clinical Trial 79 FDA Accepts 79 Psoriasis Drug 79 Cholesterol Lowering Drug 79 Osteoporosis Drug 79 Clinical Study Shows 79 Prostate Cancer Vaccine 79 Mylan Receives Approval 79 Completes Enrollment 79 Phase IIb Trial 79 Initiates Enrollment 79 Milestone Payment 79 Single Dose 79 Patients Treated With 79 Clinical Trial Evaluating 79 Intravenous Formulation 78 Arthritis Drug 78 Study Evaluating 78 Schizophrenia Treatment 78 Lung Cancer Drug 78 Investigational Treatment 78 Gout Drug 78 Combination Treatment 78 Patients Receiving 78 Phase 2b Trial 78 Phase IIb Clinical Trial 78 Phase 2a Trial 78 Epilepsy Drug 78 Teva Provides Update 78 Proven Effective 78 Drug Shows Promise 78 Treated Patients 78 Transdermal Patch 78 Clinical Trial Results 78 Shows Promising 78 Treatment Reduces 78 Combo Therapy 78 Phase 2a Clinical Trial 78 Non Invasive Treatment 78 Investigational Compound 78 Pediatric Patients 78 Beta Blocker 77 Initiates Clinical 77 Fungal Infections 77 Cypher Sirolimus 77 Clinical Trial Data 77 Kidney Transplant Patients 77 Phase III Clinical Trial 77 Osteoporosis Treatment 77 Generic Version Of 77 Rheumatoid Arthritis Drug 77 Present Preclinical Data 77 Cholesterol Drug 77 JAK Inhibitor 77 Appears Safe 77 Data Suggest 77 Granted Orphan Drug 77 Less Invasive 77 Schizophrenia Drug 77 Adjunctive Therapy 77 Reduces Pain 77 Patients Undergoing 77 Survival Benefit 77 Advanced Melanoma 77 Study Demonstrates 77 Pivotal Phase III 77 Slow Progression 77 Blood Thinner 77 IND Filing 77 Phase III Trials 77 Shows Promise Against 77 Rotavirus Vaccine 76 Rheumatoid Arthritis Patients 76 PDUFA Date 76 Shows Efficacy 76 Pivotal Study 76 Long Term Efficacy 76 Pivotal Clinical Trial 76 Demonstrates Efficacy 76 First Patient Treated 76 Significantly Improved 76 Lowers Risk 76 Taro Receives 76 Significantly Reduced 76 FDA Panel Recommends 76 Clinical Outcome 76 Drug Coated Stent 76 Significantly Reduces 76 Study Showed 76 Heart Failure Patients 76 Severe Sepsis 76 Launches Generic Version 76 PRN FDA Approves 76 Adjuvant Chemotherapy 76 Patients Suffering 76 Overactive Bladder 76 Tablet Formulation 76 Drug Combo 76 Preclinical Data 76 Shows Statistically Significant 76 Chronic Sinusitis 76 Asthma Treatment 76 Drug Prevents 76 Mg Usa 76 Diabetic Foot Ulcer 76 Phase IIa Clinical Trial 76 Develop Novel 76 Pivotal Trial 76 Patients Treated 76 Reduces Risk 76 Confirmatory Phase 75 Effectively Treats 75 Phase III Trial 75 Hypertensive Patients 75 Initiates Phase III 75 Showed Significant 75 Inhaled Insulin 75 Improved Survival 75 Topical Treatment 75 Minimally Invasive Procedure 75 Initiates Phase II 75 Pooled Analysis 75 Statistically Significant 75 ORLive Presents 75 Heartburn Drugs 75 Successfully Completes Phase 75 ACE Inhibitors 75 Inhaled Corticosteroids 75 Presents Positive 75 Antitumor Activity 75 Prophylactic Treatment 75 Fracture Risk 75 Significantly Improves 75 Parathyroid Hormone 75 Is Well Tolerated 75 Osteoporosis Drugs 75 HER2 Positive Breast Cancer 75 Cholesterol Lowering 75 Milestone Payment From 75 Fast Track Status 75 Presents Preclinical Data 75 Dose Ranging Study 75 Breast Cancer Treatment 75 Demonstrates Potential 75 Testosterone Gel 75 Vaginal Gel 75 Anticancer Drug 75 Initiates Clinical Trials 75 Advanced Colorectal Cancer 75 Low Dose 75 Dry Powder Inhaler 75 Breast Cancer Recurrence 75 Randomized Clinical Trial 75 Relapsing Multiple Sclerosis 75 Stem Cell Treatment 75 FDA APPROVES 75 Contrast Agent 75 Investigational Agent 75 Reduces Mortality 75 Diabetic Neuropathy 75 Lung Cancer Survival 75 Demonstrates Sustained 75 Renal Cancer 75 Test Detects 75 Pivotal Trials 75 Announces Tentative Approval 75 Drug Eluting 74 Unfractionated Heparin 74 Previously Treated 74 Therapy Improves 74 Contrast Agents 74 Demonstrates Statistically Significant 74 Achieves Primary Endpoint 74 Percutaneous Tibial Nerve Stimulation 74 Glatiramer Acetate 74 Novel Oral 74 Phase 1b Clinical Trial 74 Phase Ib Clinical Trial 74 Nicotine Vaccine 74 Oral Mucositis 74 Hormone Refractory Prostate Cancer 74 Pain Relievers 74 First Patient Enrolled 74 Myeloma Patients 74 Proves Effective 74 Treatment Naïve 74 Liver Failure 74 Microwave Ablation System 74 Maleate 74 Statin Drugs 74 Receives Orphan Drug 74 Knee Osteoarthritis 74 Stent Implantation 74 Prostate Cancer Patients 74 #mg Tablets [002] 74 Elderly Patients 74 Disease Modifying 74 Well Tolerated 74 Diagnostic Tests 74 Supplemental Biologics License Application 74 Anticancer Agent 74 Kidney Function 74 Files Investigational 74 Slows Progression 74 Device Maker 74 Trial Evaluating 74 Antifungal 74 Successfully Treats 74 Therapy Reduces 74 Receives Positive Opinion 74 Treatment Resistant 74 Interferon Alpha 74 Potentially Fatal 74 NAVISTAR R 74 HER2 Positive 74 Artery Disease 74 Pharmacokinetic Study 74 Anticoagulant 74 Announce Collaboration Agreement 74 Recombinant Human 74 Shingles Vaccine 74 Sagent Pharmaceuticals Announces 74 Treating Chronic 74 Improve Survival 74 Antimicrobial Coating 74 Prolongs Life 74 Renal Cell Carcinoma 74 Receives SFDA Approval 74 II Clinical Trial 73 Newly Diagnosed Multiple Myeloma 73 Node Positive 73 Mycophenolate Mofetil 73 Treatment Regimen 73 Demonstrated Significant 73 Demonstrates Potent 73 Renal Impairment 73 Anticancer Activity 73 Sirolimus Eluting Stent 73 Immunosuppressant 73 Embolic Protection 73 Estrogen Therapy 73 Receives Milestone Payment 73 Metastatic Melanoma 73 Anemia Drug 73 Fondaparinux 73 FDA Approves Generic 73 Oral Fingolimod 73 Synthetic Peptide 73 Absorbable 73 #k Clearance 73 Diuretic 73 HCV Protease Inhibitor 73 Intravitreal 73 Earns Milestone Payment 73 Multiple Myeloma Patients 73 Efficacy Trial 73 Topical Cream 73 Diabetic Patients 73 Phase III Clinical Trials 73 Patients Enrolled 73 Reduced Risk 73 Hepatitis B Vaccine 73 Generic Protonix 73 Phase 2b Study 73 Tyrosine Kinase Inhibitor 73 Partial Nephrectomy 73 Cell Transplants 73 Million Milestone Payment 73 Effective Than 73 Complicated Skin 73 Receives CE Marking 73 Weight Loss Drug 73 FDA Approval 73 Stronger Warnings 73 Lung Cancer Patients 73 Bepreve TM 73 k Clearance 73 FDA Approves 73 ANDA Filing 73 Zorbtive TM 73 Licenses Novel 73 Bone Metastases 73 Investigational Oral 73 Novel Inhibitor 73 Neoadjuvant Chemotherapy 73 Silicone Breast Implants 73 Premature Infants 73 Posaconazole 73 Efficacious 73 Medoxomil 73 Lowers Blood Pressure 73 Sinus Infections 73 Interferon Gamma 73 Plaque Psoriasis 73 Nebulized 73 Spinal Fusion 73 Improves Quality 73 Acute Heart Failure 73 Fewer Side Effects 73 Lupus Nephritis 73 Obtains CE Mark 73 Levels Linked 73 Erectile Dysfunction Drug 73 Fluconazole 73 Novel Compound 73 Anemia Drugs 73 Obese Patients 73 Minimally Invasive Treatment 73 Predict Risk 73 Device Helps 73 Extended Release 73 Urine Test 73 Surgical Procedures 73 First Patient Dosed 73 Bazedoxifene 73 BioSante Pharmaceuticals Announces 73 Initiate Phase III 73 Advanced Prostate Cancer 73 Prospective Randomized 73 Testosterone Patch 73 Begins Dosing 73 Benign Prostatic Hyperplasia 73 Hormone Receptor Positive 73 Therapeutic Vaccine 73 Acute Attacks 73 Molecular Diagnostic Test 73 vapreotide acetate 72 Thrombectomy 72 Hydrochlorothiazide Tablets 72 Wound Dressing 72 Immunomedics Announces 72 Stent Restenosis 72 Bare Metal Stents 72 Hernia Repair 72 Enlarged Prostate 72 Initiate Phase 72 Symptom Relief 72 BioElectronics Announces 72 Crit Rev 72 Guidelines Issued 72 Eluting Stent 72 Hip Implants 72 Hepatitis C Genotype 72 REMINDER ORLive Presents 72 Drug Maker 72 Seasonal Influenza Vaccine 72 See CLINICAL PHARMACOLOGY 72 Polymerase Inhibitor 72 Genes Linked 72 Successfully Treated 72 Pivotal Phase 72 Postmenopausal Osteoporosis 72 GRAS Status 72 Heart Stents 72 Positive Opinion 72 Study Shows Significant 72 Milestone Payments 72 Hepatitis C Treatment 72 Preclinical Study 72 Topical Gel 72 Receives Fast Track 72 Inflammatory Markers 72 Could Predict 72 Treatment Shows Promise 72 Plus Ribavirin 72 Bone Fracture 72 Anti Inflammatory 72 Obtains FDA 72 Announce License Agreement 72 Glaucoma Treatment 72 Peripheral Arterial 72 Systemic Delivery 72 Regenerative Cells 72 Commences Phase 72 FDA Approves Drug 72 Corneal Transplant 72 Vitrasert R 72 Increases Risk 72 Anti Nausea 72 Mg Uk 72 Collaborators Present 72 Myocardial Perfusion Imaging 72 Prostate Cancer Treatment 72 Pain Medications 72 NICE Recommends 72 Significant Improvements 72 Anti Inflammatory Drug 72 Recurrent Breast Cancer 72 Liver Damage 72 Heart Transplant Recipients 72 Eur J 72 Investigational Drug 72 Submits Biologics License Application 72 Commercialize Novel 72 Insulin Pen 72 Aortic Valve 72 Arterial Disease 72 Boosts Survival 72 Hydrochloride Injection 72 Diabetic Nephropathy 72 Bivalirudin 72 Liver Transplant Patients 72 Allogeneic 72 Weight Loss Pill 72 AnaSpec Introduces 72 Breast Cancer Cells 72 Non Invasive 72 Patient Treated 72 Tacrolimus 72 Study Casts Doubt 72 Antiplatelet 72 Genetic Tests 72 Hip Fractures 72 Cholesterol Drugs 72 STELARA TM 72 Anti Tumor 72 Mouse Model 72 Interferon Beta 72 lexidronam injection 72 Kinase Inhibitor 72 Begin Clinical Trials 72 Left Ventricular 72 Vascular Grafts 72 Secondary Hyperparathyroidism 72 Migraine Treatment 72 Intravascular 72 Urinary Tract Infections 72 Metabolic Disorder 72 FDA Warns Against 72 Inhaled Nitric Oxide 72 Adjuvant Therapy 72 VIVUS Announces 72 Randomized Trials 72 Receives CE 72 Atypical Antipsychotic 72 Fixed Dose 72 Bronchodilator 72 HCl Tablets 72 Stent Coating 72 Study Shows Benefits 72 Antiviral Drugs 72 Dose Escalation 72 Transcatheter 71 Previously Untreated 71 Muscle Wasting 71 Contrast Enhanced 71 Pulmonary Artery 71 Epilepsy Drugs 71 Bosutinib 71 Drug Eluting Coronary Stent 71 Biomarker Study 71 Receives Tentative Approval 71 Hepatic Encephalopathy 71 Infected Patients 71 Male Contraceptive 71 Premenopausal Women 71 Lung Cancer Trial 71 Catheter Ablation 71 Tezampanel 71 Gene Linked 71 Controlled Study 71 Parenteral Nutrition 71 Chemoradiation 71 Smallpox Vaccine 71 Protease Inhibitor 71 Versus Placebo 71 Patent Covering 71 Sign Licensing Agreement 71 Lanthanum Carbonate 71 Submits Supplemental 71 Acute Ischemic Stroke 71 Novel Antibiotic 71 Files Patent Application 71 Oral Cladribine 71 Robotic Assisted 71 Desvenlafaxine Succinate 71 Renal Function 71 Tumor Targeting 71 J Am Coll 71 Chemotherapy Regimen 71 Package Insert 71 Resubmission 71 Cocaine Addiction 71 Orthostatic Hypotension 71 Pegylated Interferon 71 Coronary Stents 71 Hypercholesterolemia 71 TOPAMAX R 71 Replacement Therapy 71 Release Capsules 71 gets USFDA nod 71 Disease Progression 71 Stress Urinary Incontinence 71 Aneurysm Repair 71 Submits Response 71 Oral Calcitonin 71 Drug Coated Stents 71 Shown Effective 71 Aztreonam Lysine 71 Peginterferon Alfa 2a 71 Elevated Levels 71 Blood Pressure Reduction 71 Respiratory Distress 71 HCl Injection 71 Skin Lesions 71 Chronic Hepatitis C 71 Montelukast 71 Metastatic Prostate Cancer 71 Efficacy Results 71 Aliskiren 71 Pafuramidine 71 Refractory Hodgkin Lymphoma 71 Serious Side Effects 71 REPRONEX R menotropins 71 Pneumococcal Vaccine 71 Novel Treatments 71 Adenoma 71 Severe Acne 71 Proves Successful 71 Emerging Therapies 71 Therapeutic Antibody 71 Diastolic Heart Failure 71 Desloratadine 71 Long Term Survival 71 Blocked Arteries 71 Bare Metal Stent 71 Oral Insulin 71 Sustained Release 71 Vaccine Adjuvant 71 Pulmonary Arterial Hypertension 71 PROCTOCORT R 71 Insulin Glargine 71 Demonstrate Significant 71 Surgical Sealant 71 J Clin 71 Guidelines Recommend 71 Reveals Positive 71 Eluting Coronary Stent System 71 Initiates Dosing 71 Interferon beta 1a 71 Immunomodulatory 71 Reports Preclinical Data 71 Resistant Hypertension 71 Diet Pill 71 Gum Disease 71 Treating Depression 71 Augment ™ 71 Clinically Proven 71 Fluticasone 71 Post Operative 71 Stent Placement 71 Increased Mortality 71 MR Angiography 71 Shows Promise 71 Gene Variants 71 Gene Variant 71 Levoleucovorin 71 Tumor Growth 71 Glucose Control 71 Inhalation Solution 71 Abdominal Pain 71 Sublingual 71 Subgroup Analysis 71 Transdermal Delivery 71 Chronic Hepatitis B 71 Antidepressants Linked 71 Implantable Device 71 R lenalidomide 71 Alternative Treatments 71 Breast Tumors 71 Interferon Alfa 71 Genes Associated 71 Prevent Stroke 71 Balloon Catheters 71 Blood Clotting 71 Chronic Renal Failure 71 Peginterferon 71 Endovascular Treatment 71 Adjunctive 71 SPRYCEL ® 71 Kidney Transplant Recipients 71 Cancer Treatments 71 Embolization 71 Beneficial Effects 71 Lowers Cholesterol 71 Cervical Cancer Vaccine 71 Therapeutic Competitors Companies 71 Total Knee Arthroplasty 71 Combination Therapy 71 Key Milestones 71 Budesonide 71 Partial Onset Seizures 71 Carotid Stenting 71 Invasive Fungal Infections 71 Optimer Pharma 71 Bone Marrow Transplants 71 Study Evaluates 71 Left Atrial Appendage 71 #-# Full Text 71 Viral Load 71 Oral Solution 71 Thrombotic 71 Antiepileptic Drug 70 TM Drug Eluting 70 Oral Spray 70 FDA Warns 70 Intrathecal 70 Cardiovascular Disease Risk 70 Generic Lovenox 70 Psoriasis Patients 70 Transplant Patients 70 Deep Venous Thrombosis 70 Who Underwent 70 Oral Contraceptive 70 Pegylated Liposomal Doxorubicin 70 Being Studied 70 Gene Therapy Trial 70 Commence Phase 70 Oxcarbazepine 70 SUPPRELIN R LA 70 Prognostic Value 70 Combination REOLYSIN R 70 Fibrin Sealant 70 Immune Cells 70 Cold Sores 70 Pre Cancerous 70 Recall Issued 70 Helps Predict 70 Enrolls First 70 Spinal Implant 70 Antidepressant Drug 70 Anti Tumor Activity 70 Levaquin levofloxacin 70 Novel Protein 70 Antipsychotic 70 Immune Responses 70 Sumatriptan Succinate 70 Endometrial Cancer 70 Genotyping Test 70 Curr Opin 70 Endometrial Ablation 70 Antiepileptic 70 Potent Antiviral Activity 70 Receptor Agonist 70 Double Blind Randomized 70 Ebola Vaccine 70 Receive Milestone Payment 70 Brain Metastases 70 Chronic Heart Failure 70 Detection Device 70 Smooth Muscle 70 Clinical Trial Enrollment 70 Colorectal Cancer Patients 70 R Saizen R 70 Acne Drug 70 Lower Blood Pressure 70 Aortic Valve Replacement 70 Migraine Headaches 70 Higher Doses 70 Vertebral Compression Fractures 70 Non Responders 70 Stent Thrombosis 70 Osteoarthritis Patients 70 Anti Clotting Drug 70 Weight Loss Supplement 70 Valve Replacement 70 Controlled Trial 70 Monoclonal Antibody 70 acetonide FA 70 Vaccine Candidate 70 Metastatic Colorectal Cancer 70 Electrical Stimulation 70 Insulin Pumps 70 Roche Boniva 70 Study Reinforces 70 Drug Eluting Stents 70 Obesity Linked 70 Genetic Disorder 70 Demonstrates Ability 70 Immunotherapeutic 70 Novel Mechanism 70 Infusion Pumps 70 topical gel formulation 70 Magnetic Stimulation 70 Hematopoietic Stem Cell Transplantation 70 Statin Therapy 70 JAK2 Inhibitor 70 Presents Preclinical 70 Inhalation Aerosol 70 Treatment Naive Patients 70 Diagnostic Tools 70 nizatidine 70 TNF Blockers 70 Study Validates 70 Soriatane 70 Acne Medication 70 Begins Shipment 70 Nonsurgical 70 Eszopiclone 70 Orally Active 70 Preclinical Models 70 Study Indicates 70 Thoracic Endoprosthesis 70 Critically Ill Patients 70 Could Prevent 70 Sirolimus eluting 70 Ovarian Cancer Patients 70 Clinically Tested 70 Bioresorbable 70 Inflammatory Arthritis 70 ORADUR ® 70 Pharmaceuticals Initiates 70 J Shoulder Elbow 70 Antibiotic Treatment 70 Blood Glucose Testing 70 Ondansetron Injection USP 70 Dual Antiplatelet Therapy 70 Bipolar Depression 70 Lung Cancer Treatment 70 Oxybutynin 70 Seasonal Allergic Rhinitis 70 Receives Complete Response 70 Sustained Reduction 70 Randomized Study 70 TM Everolimus Eluting 70 Protease Inhibitors 70 Sevelamer 70 SFDA Approval 70 Proton Pump Inhibitors 70 vinorelbine tartrate 70 Blood Clots 70 Invasive Breast Cancer 70 Often Misdiagnosed 70 Confirms Efficacy 70 cromolyn sodium 70 Anticancer Compound 70 Liver Injury 70 include Phenoptin TM 70 Tartrate 70 Pain Medication 70 Xcytrin R 70 Myocardial Ischemia 70 markets COLAZAL 70 Myoblast 70 Prove Effective 70 Coronary Arteries 70 Melphalan 70 Sleep Disturbances 70 CDC Recommends 70 Liver Toxicity 70 Antitumor 70 Randomized Double Blind 70 Erosive Esophagitis 70 CT Angiography 70 Hormone Therapy 70 Meta Analysis 70 Liver Tumors 70 Acne Scars 70 Balloon Catheter 70 FDA Approvable Letter 70 dual endothelin receptor antagonist 70 ARIXTRA R 70 Fabry Disease 70 Treat Anemia 70 Aortic Aneurysm 70 Indomethacin 70 Dialysis Patients 70 Begins Clinical Trial 70 Therapy Shows Promise 70 Treatment Naïve Patients 70 Ablation System 70 Generic Equivalent 70 Fentanyl Patch 70 Bone Marrow Cells 70 Bone Graft 70 Venous Thromboembolism 70 Kidney Failure 70 Wound Dressings 70 Impotence Drug 70 Gastric Cancer 70 Atypical Antipsychotics 70 MetroGel 70 Dose Finding 70 ALN HPN 70 Atopic Dermatitis 70 Oral Formulation 70 Epoetin Alfa 70 Help Detect 70 Infarct 70 Initiates Phase 2b 70 Surgical Technique 69 Peptic Ulcer 69 Pramlintide 69 Drug Resistant 69 Physician Insights 69 Suppositories 69 Genetic Mutation 69 Myelodysplastic Syndromes 69 RNAi Therapeutic 69 Antiviral Activity 69 Cardiotoxicity 69 Renal Artery 69 Cosmetic Procedure 69 Calcium Supplements 69 Breast Biopsy 69 Divalproex Sodium 69 Clinical Efficacy 69 Androgen Deprivation Therapy 69 Kuvan TM sapropterin 69 Naive Patients 69 Achieves Milestone 69 Skeletal Muscle 69 Brain Atrophy 69 ALVESCO ® 69 Oral Fluid 69 Gonal f R 69 Relapsed Refractory 69 aripiprazole Abilify 69 Protein Biomarker 69 Attenuates 69 Thrombectomy System 69 Drug Combinations 69 Delayed Release 69 Gastrointestinal Disorders 69 Hemodialysis Patients 69 Danazol 69 Beta Blockers 69 Carotid Artery Stenting 69 Transdermal System 69 Septic Shock 69 Cinacalcet 69 Subtypes 69 Gene Mutation 69 Antipsychotic Drugs 69 Submits Application 69 Lung Injury 69 Platinol ® 69 Clinical Evaluation 69 Randomized Clinical Trials 69 Assay Kits 69 Ventricular Assist Devices 69 ST Elevation Myocardial 69 Gliadel R 69 Advanced Renal Cell 69 Presents Positive Preclinical 69 Sustained Efficacy 69 Demonstrates Superior 69 Stomach Ulcer 69 Autologous Stem Cell Transplantation 69 Predict Response 69 Further Validates 69 Sirolimus Eluting 69 Thrombus 69 FS Antihemophilic Factor Recombinant 69 TO AVOID PREGNANCY WHILE 69 Receives Patent 69 Help Diagnose 69 metastatic malignant 69 Endothelial Dysfunction 69 Radioimmunotherapy 69 Patency 69 Silicone Implants 69 Monotherapy 69 Transplant Rejection 69 Antibiotic Resistant 69 Phase III Pivotal 69 Mimetics 69 Could Save Lives 69 Inflammatory Disease 69 Stakeholder Opinions 69 Pegylated 69 Preterm Labor 69 Radiofrequency Ablation RFA 69 Neuroprotective Effects 69 Pegloticase 69 #mg/#mg 69 Skin Resurfacing 69 Patents Covering 69 INFeD ® 69 CHMP Opinion 69 Aurora Kinase 69 VIVITROL ® 69 Small Bowel 69 Novel Anti Inflammatory 69 Initiates Phase 69 Helps Identify 69 Moxifloxacin 69 Genes Involved 69 FOR WELL BEING 69 Nasal Sprays 69 Vertebral Fracture 69 Protein Linked 69 Drug Eluting Stent 69 Vicriviroc 69 Lung Tumors 69 Healthbeat Report 69 Therapeutic Efficacy 69 Genes Predict 69 Oral Cavity 69 Could Detect 69 Virus Linked 69 Contaminant Found 69 Commonly Used 69 Breast Implant 69 Hematological Malignancies 69 Breast Cancer Patients 69 Blood Vessels 69 AFREZZA TM 69 Cardiovasc 69 Treating Heart Failure 69 Circulating Tumor Cells 69 SBIR Grant 69 Completes Dosing 69 Vascular Graft 69 Virus Infection 69 Migraine Headache 69 Bioartificial Liver 69 Significant Improvement 69 Telithromycin 69 Antithrombin 69 Soy Isoflavones 69 COLAZAL R 69 REPRONEX ® menotropins 69 Capsules CII 69 Recurrent Ovarian Cancer 69 VISICOL R 69 Asthma COPD 69 Treatment Experienced 69 Blood Thinning 69 Terbinafine 69 Biphasic 69 Reflux Disease 69 Blood Pressure Drugs 69 Hepatocellular Carcinoma 69 Helps Prevent 69 Improve Outcomes 69 Paclitaxel Carboplatin 69 Hydralazine 69 DUROS 69 Verapamil 69 Peripherally Inserted Central 69 Injection Site 69 Prodrug 69 Platelet Inhibition 69 Arthritis Drugs 69 Embolic 69 Camptosar ® 69 Antigen Specific 69 Lamotrigine 69 Carotid Stent 69 ketoconazole USP Gel 69 Long Term Outcomes 69 OSMOPREP TM 69 Tissue Engineered 69 Significantly Increases 69 Announces Initiation 69 Osteoarthritis Pain 69 Placebo Controlled Trial 69 Surgical Mesh 69 CYPHER R Sirolimus Eluting 69 Anti infective 69 Systemic Sclerosis 69 Contaminated Heparin 69 Widely Used 69 Central Retinal Vein 69 Coronary Angiography 69 Thrombin 69 Holds Promise